1. Home
  2. LSF vs ELUT Comparison

LSF vs ELUT Comparison

Compare LSF & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Laird Superfood Inc.

LSF

Laird Superfood Inc.

HOLD

Current Price

$2.36

Market Cap

23.8M

ML Signal

HOLD

Logo Elutia Inc.

ELUT

Elutia Inc.

HOLD

Current Price

$0.74

Market Cap

23.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSF
ELUT
Founded
2015
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Medical Specialities
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.8M
23.3M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
LSF
ELUT
Price
$2.36
$0.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$12.00
$7.00
AVG Volume (30 Days)
193.6K
557.8K
Earning Date
02-25-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$48,146,862.00
$21,746,000.00
Revenue This Year
$18.05
N/A
Revenue Next Year
$17.53
N/A
P/E Ratio
N/A
N/A
Revenue Growth
17.73
24.08
52 Week Low
$1.98
$0.50
52 Week High
$8.26
$3.65

Technical Indicators

Market Signals
Indicator
LSF
ELUT
Relative Strength Index (RSI) 48.08 60.41
Support Level $2.23 $0.60
Resistance Level $2.41 $0.73
Average True Range (ATR) 0.25 0.08
MACD 0.07 0.02
Stochastic Oscillator 59.42 82.96

Price Performance

Historical Comparison
LSF
ELUT

About LSF Laird Superfood Inc.

Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

Share on Social Networks: